INS and type 2 diabetes mellitus: We should pay an attention to the development of diabetic ketoacidosis when we use SGLT2i for patients who were diagnosed with type 2 diabetes and who were subsequently found to have latent autoimmune diabetes of adulthood, patients who had recently undergone major surgery, or patients who had decreased or discontinued insulin [31].